PVLA — Palvella Therapeutics Inc. stock price and chart

Share this page

PVLA

$120.30-5.53%

as of close, Oct 16, 2026

☾ AH $120.30 -5.53%

Palvella Therapeutics Inc.Stock · HealthcareRussell 2000 0.05%Nasdaq Composite 0.004%Russell 3000 0.003%US Stock Market 0.003%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeS

20162019202120242026

100.0200.0300.0400.0500.0600.0700.005.0M$120.30

2026-10-16

Price$120.30

MA20$136.78

MA50$109.43

Vol1.4M

What would $1,000 invested in PVLA be worth today? →

PVLA returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $120.30
YTD price return: +14.93%
YTD total return: +14.93%
Next earnings: Nov 10, 2026
Market cap: 1.7B2016-12 4.8B2026-10 1.7B-64.1% over the window
Enterprise value: 1.5B
Shares outstanding: 14.4M2016-06 43.1M2026-06 14.4M-66.5% over the window
52W low: $68.96
52W high: $161.38
From 52W high: -25.46%
From 52W low: +74.45%
52W range: 56%

Volume

Rel volume: 0.78×
30D volume: 229.1K
30D $ vol: 32.3M

Fundamentals

EPS (ttm): -$4.902020-06 -$0.232026-06 -$4.90+2054.0% over the window
FCF (ttm): -25.2M2015-12 -13.3M2024-09 15M-212.7% over the window
FCF/share: -$1.752015-12 -$0.332024-09 $11.37-3499.0% over the window
Book value/share: $15.052016-06 $0.872026-06 $15.05+1637.9% over the window
ROE: -28.45%2016-06 -45.2%2026-06 -28.4%-37.1% over the window
ROA: -24.34%2016-06 -36.3%2026-06 -24.3%-33.0% over the window
Current ratio: 21.182016-06 6.842026-06 21.18+209.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: -97.12%2023-09-30 → 2024-09-3047.4M → 1.4M (-97.1% total)-62.10%2021-09-30 → 2024-09-3024.9M → 1.4M (-94.6% total)-47.49%2019-09-30 → 2024-09-3033.9M → 1.4M (-96.0% total)n/a
Shares: +30.30%2025-06-30 → 2026-06-3011.1M → 14.4M (+30.3% total)-47.37%2023-06-30 → 2026-06-3098.9M → 14.4M (-85.4% total)-26.40%2021-06-30 → 2026-06-3066.7M → 14.4M (-78.4% total)-10.37%2016-06-30 → 2026-06-3043.1M → 14.4M (-66.5% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: -97.31%2023-09-30 → 2024-09-30$38.31 → $1.02 (-97.3% total)+43.72%2021-09-30 → 2024-09-30$0.34 → $1.02 (+196.9% total)+10.66%2019-09-30 → 2024-09-30$0.62 → $1.02 (+66.0% total)n/a
Book value/share: +248.69%2025-06-30 → 2026-06-30$4.32 → $15.05 (+248.4% total)+232.35%2023-06-30 → 2026-06-30$0.41 → $15.05 (+3573.9% total)+84.71%2021-06-30 → 2026-06-30$0.70 → $15.05 (+2049.1% total)+33.05%2016-06-30 → 2026-06-30$0.87 → $15.05 (+1637.9% total)
Price: +64.54%2025-10-16 → 2026-10-16$73.14 → $120.30 (+64.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+76.15%2023-10-16 → 2026-10-16$22.00 → $120.30 (+446.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-19.71%2021-10-15 → 2026-10-16$360.80 → $120.30 (-66.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.98%2016-10-14 → 2026-10-16$132.80 → $120.30 (-9.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +64.54%2025-10-16 → 2026-10-16$73.14 → $120.30 (+64.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+76.15%2023-10-16 → 2026-10-16$22.00 → $120.30 (+446.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-19.71%2021-10-15 → 2026-10-16$360.80 → $120.30 (-66.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-0.98%2016-10-14 → 2026-10-16$132.80 → $120.30 (-9.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -24.6×2016-12 -252.842026-10 -28.13-88.9% over the window
Fwd P/E: -18.5×
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 8.0×2016-12 153.732026-10 8.00-94.8% over the window
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -1.45%2016-09 -0.2%2024-09 68.6%-30764.2% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 14.4M ÷ 11.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -30.30%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-30.30%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($249.3M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -30.30%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-230M) ÷ today's market cap ($1.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -13.27%2016-09 0.0%2026-06 -10.4%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-230M + TTM dividends $0) ÷ today's market cap ($1.7B). Same caveat as the cash buyback yield.: -13.27%2016-09 0.0%2026-06 -10.4%

Vs own 10Y history

P/S: 86th
P/B: 12th
P/FCF: 46th

Bar = where today’s multiple sits in PVLA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-5.53%

-13.31%

-20.56%

-18.59%

YTD

+14.93%

+64.48%

-66.66%

Financial statements

Open full PVLA financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

PVLA — Palvella Therapeutics Inc. price, chart and key statistics